Dissemin is shutting down on January 1st, 2025

Published in

Royal Society of Chemistry, RSC Advances, 56(6), p. 50923-50932, 2016

DOI: 10.1039/c6ra07763c

Links

Tools

Export citation

Search in Google Scholar

Selective topotecan delivery to cancer cells by targeted pH-sensitive mesoporous silica nanoparticles

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Topotecan (TOP), a water-soluble derivative of camptothecin, is a potent antitumor agent that is receiving growing attention for the treatment of several types of cancer. However, one of the major constraints in the clinical use of this drug is its inactivation at the physiological pH of 7.4. Mesoporous silica nanoparticles (MSNs) constitute promising nanocarriers to circumvent this issue. Herein TOP has been encapsulated into MSNs and the nanosystem has been provided with selectivity towards tumor cells, which permits releasing the active form of the molecule at the acidic cell compartments (endo/lysosomes; pH